Pharma Reviews: 2016: A mixed bag for Indian pharma

This is the largest overseas acquisition by an Indian pharma company. Intas is backed by PE giant Temasek and Chrys Capital. This clearly showed ...
Read more: 2016: A mixed bag for Indian pharma